Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing...
Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing that its weight-loss drug Qsymia was available in the U.S. market. The announcement was also made on its website, Qsymia.com. Peer competitor Arena Pharmaceuticals (ARNA +1%) also gets a lift on the news, in spite of the fact that its weight-loss drug, Belviq, won't be available until 2013.
From other sites
at Zacks.com (Feb 25, 2015)
at Benzinga.com (Feb 24, 2015)
at Benzinga.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
at Benzinga.com (Dec 30, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs